Veracyte, Inc.
VCYT
Rangering i aksjer
#4353
Veracyte, Inc. operates as a diagnostics company in the United States and... Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Aksjekurs
$44.93
Sist synkronisert: 2026-10-20
Markedsverdi
$3.61B
Endring (1 dag)
2.57%
Endring (1 år)
24.45%
Land
US
Handel Veracyte, Inc. (VCYT)
Kategori
Healthcare
Antall utestående aksjer for Veracyte, Inc. (VCYT)
Antall utestående aksjer per June 2026: 79.76M
Ifølge Veracyte, Inc. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 79.76M. Ved slutten av December 2023 hadde selskapet 72.64M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Veracyte, Inc. (VCYT) fra 2011 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 79.76M | 4.28% |
| 2024 | 76.48M | 5.29% |
| 2023 | 72.64M | 1.53% |
| 2022 | 71.55M | 5.39% |
| 2021 | 67.89M | 27.52% |
| 2020 | 53.24M | 15.39% |
| 2019 | 46.14M | 24.63% |
| 2018 | 37.02M | 9.12% |
| 2017 | 33.93M | 17.67% |
| 2016 | 28.83M | 11.12% |
| 2015 | 25.94M | 19.89% |
| 2014 | 21.64M | 420.34% |
| 2013 | 4.16M | -70.70% |
| 2012 | 14.20M | 0.00% |
| 2011 | 14.20M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 371.00M | 365.17% |
US
|
|
| 705.30M | 784.33% |
US
|
|
| 143.28M | 79.65% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 253.58% |
US
|
